Xconomy | Boston - Business + Technology in the Exponential Economy

Private Equity, deals, Biotech

U.S. Genomics Gets $4.5M, Enters Partnership

Gregory T. Huang 9/23/08

Woburn, MA-based U.S. Genomics, a maker of single-molecule technologies for biodefense and diagnostics, announced today it has raised $4.5 million in private equity funding from Becton, Dickinson & Co. The deal marks the start of a strategic partnership between the firms to develop an infectious-disease diagnostic platform.


Reader Comments

  • Scientist
    10/7/08 8:08 pm

    U.S Genomics is a waste of time. These people are a joke. It will be like this economic crisis we are in. They will complete their job when we can’t afford it or when too many lives are lost. They will develop a biosensor when it’s too late. Do we really need more this dysfunction in corporations anymore? Give me a break.

    Thank God John Canepa actually got a spine the past year and stopped promoting U.S Genomics. Looks like he is sick of U.S Genomics too. Their high turnover explains it all. Now they are what they deserve to be - a small start up company destined never to succeed in this real world. The truth is out - U.S Genomics may not have failed but they are a laughing matter. Everyone knows they are being laughed at except for them. It is not surprising anymore after watching 4+ years of their small ups and miserable downs.

    Don’t waste your time with U.S Genomics. They are fakes. There are more serious scientists who have hearts in their work. U.S Genomics scientists don’t even care anymore, and frankly we are sick and tired of them. Sick of watching take all the money, progress like turtles, acting like lazy bums, and get paid. Corporate greed anyone? Be forewarned that U.S Genomics will get even greedier.

  • Scientist
    10/7/08 8:10 pm

    U.S Genomics is a waste of time. These people are a joke. It will be like this economic crisis we are in. They will complete their job when we can’t afford it or when too many lives are lost. They will develop a biosensor when it’s too late. Do we really need more this dysfunction in corporations anymore? Give me a break.

    Thank God John Canepa actually got a spine the past year and stopped promoting U.S Genomics. Looks like he is sick of U.S Genomics too. Their high turnover explains it all. Now they are what they deserve to be - a small start up company destined never to succeed in this real world. The truth is out - U.S Genomics may not have failed but they are a laughing matter. Everyone knows they are being laughed at except for them. It is not surprising anymore after watching 4+ years of their small ups and miserable downs.

    Don’t waste your time with U.S Genomics. They are fakes. There are more serious scientists who have hearts in their work. U.S Genomics scientists don’t even care anymore, and frankly we are sick and tired of them. Sick of watching take all the money, progress like turtles, acting like lazy bums, and get paid. Corporate greed anyone? Be forewarned that U.S Genomics will get even greedier.

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.